14563-1-AP

antibody from Proteintech Group

Targeting: CDR2L HUMPPA

Western blot (Supportive data in Antibodypedia)

ELISA (Data presented on provider website)

Immunocytochemistry (Supportive data in Antibodypedia)

Immunoprecipitation (Supportive data in Antibodypedia)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

14563-1-AP

Provider

Proteintech Group

Proper citation

Proteintech Cat#14563-1-AP, RRID:AB_2076740

Product name

CDR2L antibody

Antibody type

Polyclonal

Description

CDR2L antibody (Cat. #14563-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP,ELISA.

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Variant-specific interaction of kinectin 1 with the multi-tRNA synthetase complex regulates ER sheet organization.

Hosogane M, Siao SY, Hatano A, Huang X, Shichino Y, Watanabe Y, Iwasaki S, Matsumoto M, Nakayama K
iScience 2026 Jan 16;29(1):114303

---

ALKBH1-mediated N6-methyladenosine methylation of TRAF1 promotes osteosarcoma proliferation and metastasis.

Wang Z, Fang Y, Yu Y, Pan H
American journal of cancer research 2025;15(1):375-389

---

CDR2 is a dynein adaptor recruited by kinectin to regulate ER sheet organization.

Teixeira V, Singh K, Gama JB, Celestino R, Carvalho AX, Pereira P, Abreu CMC, Dantas TJ, Carter AP, Gassmann R
bioRxiv : the preprint server for biology 2024 Nov 6;

---

Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue.

Raspotnig M, Kråkenes T, Herdlevær I, Haugen M, Vedeler C
Journal of neuroimmunology 2022 Jan 15;362:577766

---

Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.

Herdlevaer I, Kråkenes T, Schubert M, Vedeler CA
Annals of clinical and translational neurology 2020 Nov;7(11):2231-2242

---

Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.

Raspotnig M, Haugen M, Thorsteinsdottir M, Stefansson I, Salvesen HB, Storstein A, Vedeler CA
Cancer immunology, immunotherapy : CII 2017 Nov;66(11):1463-1471

---

Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis.

Schubert M, Panja D, Haugen M, Bramham CR, Vedeler CA
Acta neuropathologica 2014 Dec;128(6):835-52

Western blot

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

SH-SY5Y cells were subjected to SDS PAGE followed by western blot with 14563-1-AP(CDR2L antibody) at dilution of 1:500

Sample type

cell line

Immunocytochemistry

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

The CDR2L antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human CDR2L. This antibody recognizes human,mouse,rat antigen. The CDR2L antibody has been validated for the following applications: ELISA, WB, IP, IF analysis.

Appendix

14563-1-AP.pdf

Show more

Immunoprecipitation

Supportive validation

Submitted by

Proteintech Group (provider)

Main image

Experimental details

IP Result of anti-CDR2L (IP:14563-1-AP, 3ug; Detection:14563-1-AP 1:500) with SH-SY5Y cells lysate 2500ug.

Sample type

cell line